Meena LaCorte

TL;DR: Major changes in both obstetric and neonatal care during the 1990s were associated with decreases in mortality and morbidity for VLBW infants during the first half of the decade, but since 1995, no additional improvements in mortality or morbidity have been seen, ending a decades-long trend of improving outcomes for these infants.

TL;DR: In extremely low birth weight infants, maintaining a higher hemoglobin level results in more infants receiving transfusions but confers little evidence of benefit.

TL;DR: Maintaining the hemoglobin of extremely low birth weight infants at these restrictive rather than liberal transfusion thresholds did not result in a statistically significant difference in combined death or severe adverse neurodevelopmental outcome.

TL;DR: Six neonatal intensive care units that are members of the Vermont Oxford National Evidence-Based Quality Improvement Collaborative for Neonatology collaborated to reduce infection rates to provide a basis for an evidence-based approach to lowering nosocomial infection rates.

TL;DR: Although the results cannot justify any conclusion about the relative efficacy of fluconazole versus nystatin in prevention of SFI, the significantly higher mortality rate in the nyStatin group raises questions about therelative safety of this medication.